MetLife Inc. Common Stock vs SS&C Technologies Holdings Inc. Common Stock — how do they compare? MetLife Inc. Common Stock trades at $100.15 (market cap $63.37B), while SS&C Technologies Holdings Inc. Common Stock trades at $82.08 (market cap $19.25B). The key difference: MetLife Inc. Common Stock is far larger — about 3.3× SS&C Technologies Holdings Inc. Common Stock's market cap, and MetLife Inc. Common Stock pays the higher dividend (2.38%). Which is the better fit depends on your goals — on Pluang, investors hold MetLife Inc. Common Stock for 6 Days and SS&C Technologies Holdings Inc. Common Stock for 0 Days on average.
| MET | SSNC | |
|---|---|---|
Market Cap | $63.37B | $19.25B |
Volume | 3,698,294 | 1,341,767 |
Sector | Financials | Technology |
52-Week High | $100.65 | $89.62 |
52-Week Low | $67.70 | $62.05 |
Typical Hold Time | 6 Days | 0 Days |
Enterprise Value | $84.30B | $26.59B |
Dividend Yield | 2.38% | 1.46% |
Signals from Pluang's Aura AI — not financial advice
MetLife (MET) trades at $100.65, up 0.48% on the day, with a bullish technical signal from moving averages and strong analyst support. The company has consistently beaten earnings estimates in recent quarters, with a P/E of 19.28 and a net income margin of 4.66%. Recent news highlights a declared dividend of $0.59 per share and upcoming Q3 2026 results.
The outlook for MET is positive, driven by earnings momentum and a favorable interest rate environment for insurers. Key risks include investment income volatility and competitive pressures. With a consensus price target of $108.25 and no sell ratings, Wall Street sentiment remains bullish, though the stock's RSI suggests potential near-term overbought conditions.
SSNC trades at $81.52, up 0.65% on the day, with a neutral technical signal. The company has consistently beaten earnings estimates in recent quarters (Q4 2025, Q1 2026, Q2 2026) and shows solid fundamentals, including a 13.16% net income margin and 12.73% ROE. Recent news highlights new client wins and AI-driven product enhancements, reinforcing its market position.
The outlook is positive, supported by strong analyst consensus (70.83% Buy rating) and a $91.50 price target, implying ~12% upside. Key risks include execution of growth initiatives and competitive pressures in the financial technology sector. The stock presents a compelling opportunity for investors seeking a fundamentally sound company with recurring revenue streams.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
MetLife provides insurance, annuities, employee benefits, and asset management services. Its products serve individuals, employers, and institutions.
Read more on MET →SS&C Technologies Holdings, Inc. provides software and outsourced services for financial services and healthcare organizations, covering fund accounting, portfolio management, trading support, and regulatory reporting, and operates as a hedge fund and private equity administrator and mutual fund transfer agent.
Read more on SSNC →